1. Home
  2. FBYD vs ZVRA Comparison

FBYD vs ZVRA Comparison

Compare FBYD & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Falcon's Beyond Global Inc.

FBYD

Falcon's Beyond Global Inc.

HOLD

Current Price

$10.64

Market Cap

868.0M

Sector

N/A

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.63

Market Cap

766.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBYD
ZVRA
Founded
2021
2006
Country
United States
United States
Employees
243
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
868.0M
766.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FBYD
ZVRA
Price
$10.64
$9.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
211.8K
1.3M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
N/A
$53.42
P/E Ratio
$268.88
$20.87
Revenue Growth
N/A
350.91
52 Week Low
$3.71
$7.16
52 Week High
$29.02
$15.04

Technical Indicators

Market Signals
Indicator
FBYD
ZVRA
Relative Strength Index (RSI) 37.35 28.04
Support Level $10.06 $8.26
Resistance Level $12.88 $11.07
Average True Range (ATR) 1.81 0.74
MACD -0.52 -0.39
Stochastic Oscillator 12.44 8.85

Price Performance

Historical Comparison
FBYD
ZVRA

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: